Differential immune profiles in the context of chronic stress among childhood adversity-exposed adolescents.

Brain Behav Immun

Department of Psychological Science, School of Social Ecology, University of California Irvine, Irvine, CA, USA; Department of Psychiatry & Human Behavior, School of Medicine, University of California Irvine, Irvine, CA, USA; Department of Psychiatry, Children's Hospital of Orange County (CHOC), Orange, CA, USA.

Published: March 2025

Psychosocial stress has been linked to myriad mental and physical health conditions. Stress-induced changes to functioning of the immune system is a plausible mechanism in this association. Psychosocial stress is a well-established contributor to immune dysregulation, though the extant literature to date falls short of addressing the role of distal relative to contemporary stress in immune function, particularly as they relate to distinctions between innate and adaptive immunity. The present study directly addressed this knowledge gap by characterizing vertically-integrated markers of immune functioning as a function of both recent chronic stress during adolescence and childhood adversity. In the present study, childhood adversity (before age 10) and recent psychosocial stressors (past 6 months) were characterized via semi-structured clinical interviews among 127 adolescent girls (aged 13-17; 31 % Black, 38 % Hispanic, 32 % NHW) who have all measures included in this report. Vertically-integrated markers of immune activity were also collected: an a priori subset of immune-related genes using genome-wide transcriptional profiling, an 11-plex of circulating cytokines (IL-6, TNF-α, IL-10, IL-8, IFN-γ, IL-1β, IL-1α, IL-27, MCP-1, IL-12p70, IP-10), and systemic inflammation (C-reactive protein; CRP). The association between recent chronic stress and intracellular immune outcomes differed based on childhood adversity. Genome-wide transcriptional profiling implicated myeloid lineage cells, specifically monocytes and dendritic cells, in differential patterns of gene expression among childhood adversity-exposed youth in the context of chronic stress. These differential patterns were also reflected in expression of proinflammatory genes and CRP such that among adolescents without exposure to childhood adversity, more recent chronic stress was associated with less proinflammatory gene expression, b = -0.45 (SE = 0.22), p = 0.04, 95 %CI [-0.87, -0.02], and somewhat higher CRP, b = 0.62 (SE = 0.35), p = 0.08, 95 %CI [-0.07, 1.31], while among adolescents with exposure to childhood adversity, more recent chronic stress was not associated with any immune activity markers. However, these patterns among circulating markers did not survive corrections for multiple comparisons. Immune adaptation in the context of chronic stress may indicate plasticity to environmental demands that conserves biological resources, which may be a source of resilience that is negatively impacted by childhood adversity.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbi.2025.03.004DOI Listing

Publication Analysis

Top Keywords

chronic stress
28
childhood adversity
24
context chronic
12
stress
10
childhood
8
childhood adversity-exposed
8
psychosocial stress
8
immune
8
vertically-integrated markers
8
markers immune
8

Similar Publications

Article Synopsis
  • Asthma is a chronic respiratory disease involving inflammation and other respiratory issues, with mitochondria playing a crucial role in its underlying mechanisms.
  • A bibliometric analysis of research from 2004 to mid-2024 identified 669 publications, showing significant growth in studies since 2015, primarily from the US, China, and the UK.
  • Key themes include mitochondrial dysfunction and oxidative stress, with emerging research focusing on mitochondrial biogenesis and the NLRP3 inflammasome, suggesting opportunities for new therapeutic strategies targeting mitochondria in asthma treatment.
View Article and Find Full Text PDF
Article Synopsis
  • The respiratory system is vital for oxygen absorption and carbon dioxide expulsion, helping to maintain the body's acid-base balance and metabolic stability.
  • The outbreak of COVID-19 has highlighted the need for new treatments for respiratory diseases, leading to renewed interest in Tanshinone IIA, a bioactive compound traditionally used for heart diseases.
  • Research shows Tanshinone IIA has various therapeutic effects, including anti-inflammatory and anti-cancer properties, and it shows promise in treating conditions like asthma and lung cancer, making it a valuable focus for future studies.
View Article and Find Full Text PDF

HRR as a predictor of lung health: insights from the NHANES database.

Front Med (Lausanne)

February 2025

Department of Thoracic Surgery, Wuxi People's Hospital, Nanjing Medical University, Wuxi Medical Center, Wuxi, China.

Background: Chronic respiratory diseases (CRPD) are a global health threat characterized by oxidative stress, systemic inflammation, hypoxemia, and respiratory distress. Inflammatory indicators such as hemoglobin-to-red blood cell distribution width ratio (HRR) have been explored in relation to diseases of the respiratory system, but the correlation between HRR and pulmonary function has not been established. As part of this study, a representative sample of the National Health and Nutrition Examination Survey (NHANES) respondents aged 40 or over was used to examine the correlation between HRR and pulmonary function indices.

View Article and Find Full Text PDF

Background: Chronic obstructive pulmonary disease (COPD) has become a major global healthcare issue due to its high prevalence and mortality rates. Increasing evidence suggests that autophagy plays a role in the development of COPD, yet there is a lack of bibliometric analyses on literature related to autophagy and COPD. Therefore, this study aims to summarize the current research status, research direction, and research hotspots in the literature related to COPD and autophagy.

View Article and Find Full Text PDF

The new 2024 European guideline on chronic coronary syndromes (CCS) is a pivotal document for clinical practice, updating the evidence and indications after five years, incorporating insights from the paradigm-shifting ISCHEMIA trial. This article explores the evolving role of functional and anatomical testing in assessing coronary artery disease (CAD), highlighting the introduction of a new risk probability score based on clinical and risk factors. Additionally, it provides a detailed comparison between these European recommendations and those from the most influential American guidelines, emphasizing key differences in the approach to risk stratification and diagnostic strategies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!